Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Rare Cannabinoid Company launches world's first CBGA + CBDA + Hawaiian CBD Oil Tincture


News provided by

Rare Cannabinoid Company

May 05, 2022, 04:55 ET

Share this article

Share toX

Share this article

Share toX

Rare Cannabinoid Company launches a new 1500mg CBGA + CBDA + Full Spectrum Hawaiian CBD Oil Tincture.
Rare Cannabinoid Company launches a new 1500mg CBGA + CBDA + Full Spectrum Hawaiian CBD Oil Tincture.

Rare Cannabinoid Company announces the launch of its newest hemp-derived product: a 1500mg full spectrum cannabinoid tincture containing equal parts CBGA (cannabigerolic acid), CBDA (cannabidiolic acid), and full spectrum Hawaiian CBD (cannabidiol). The high strength oil is designed for immune support and joins the premium brand's oils and gummies of THCV, CBDV, CBC, CBG, CBN, CBDA, CBD, and terpenes.

HONOLULU, Hawaii, May 4, 2022 /PRNewswire-PRWeb/ -- Rare Cannabinoid Company announced the launch of its 1500mg CBGA + CBDA + CBD oil tincture. The full spectrum oil is designed for immune support and contains equal parts of CBGA (cannabigerolic acid), CBDA (cannabidiolic acid), and full spectrum Hawaiian CBD (cannabidiol). Buy CBGA + CBDA + CBD here.

"We formulated this Support+ tincture after receiving many requests from stores and individual customers for a high strength blend of CBGA, CBDA, and CBD," said a company spokesperson.

We formulated this Support+ tincture after receiving many requests from stores and individual customers for a high strength blend of CBGA, CBDA, and CBD.

Post this

"As we head into the summer season and travel increases to levels not seen since the COVID-19 pandemic started, we hope this supportive blend of cannabinoids will help people feel their best."

In addition to supporting a healthy immune system, CBDA and CBGA may relieve occasional nausea, soreness, discomfort, and inflammation after exercise. CBD (cannabidiol) supports a sense of calm, balance, healthy joints and mental and physical well-being.

A leader in non-psychoactive rare cannabinoids, the aptly named Rare Cannabinoid Company is the first to release this combination of CBGA, CBDA, and Hawaiian CBD. It was also the first to formulate purified oils of THCV (tetrahydrocannabivarin) and CBDV (cannabidivarin) as well as terpene-only tinctures.

While CBD has become a well-known health and wellness product, interest in these rare hemp compounds is now growing exponentially. This is because each rare cannabinoid offers unique effects and benefits.

The premium brand's most-popular products have wide appeal for their targeted benefits. For example, THCV acts like a stimulant, increasing energy and suppressing appetite, which may aid weight loss. CBN (cannabinol) is believed to be the most-sedative cannabinoid and supports relaxation and restful sleep. Meanwhile, CBG (cannabigerol) relieves pain and inflammation after exercise. Rare Cannabinoid Company sells pure cannabinoid isolate oils, full spectrum blends, as well as THCV gummies, CBN gummies, CBG gummies and CBD gummies.

In addition to their most-popular cannabinoid oils and gummies, the brand specializes in unique products -- such as CBDV, which is being studied for potential benefits for autism spectrum disorder -- and this new formula of CBGA, CBDA, and CBD.

For those asking "What is CBGA? What is CBDA?," Rare Cannabinoid Company explains that they are acidic precursors to CBG and CBD. CBGA and CBDA are found in abundance in living, growing hemp and cannabis plants. However, for people to receive CBGA and CBDA benefits, they must consume them in their raw, unheated form. If they are smoked, baked, or vaped they will turn into CBG and CBD respectively.

The new, high strength tincture combines 500mg CBGA isolate with 500mg CBDA isolate and 500mg full spectrum Hawaiian CBD. The CBD oil is extracted from hemp plants grown on the slopes of Haleakala Volcano on the Hawaiian island of Maui.

"We believe that cannabinoids work best when they are combined with each other for the entourage effect," said the spokesperson.

The entourage effect is a phenomenon whereby cannabis and hemp compounds act synergistically with each other and enhance one another's effects.

"By combining a high level of CBGA with a high level of CBDA and enhancing it with another 500mg of full spectrum CBD, and all of its phytocannabinoids and terpenes, this all increases each cannabinoid's potential benefits."

Rare Cannabinoid Company grew out of its sister brand, Hawaiian Choice, which is Hawaii's most-popular CBD brand. The husband-wife founders of Hawaiian Choice started the new company when their customers started asking about where to buy specific rare cannabinoids. At the time, interest was limited to CBN for sleep, CBG for inflammation, THCV for weight loss potential, and CBC for improved mood. However, the team knew that as more and more rare cannabinoids were able to be extracted from hemp that interest in their unique benefits would grow too.

They designed the new company to offer an apothecary of cannabinoids and terpenes for people to mix and match with each other and create their own custom blends. In this way, they could offer a truly personalized health and wellness offering.

Rare Cannabinoid Company was started in the first quarter of 2020. Despite the COVID-19 pandemic, it grew very quickly as interest in rare or minor cannabinoids exploded. It is now the market leader in non-psychoactive rare cannabinoids, with products sold online and in around 300 locations across the United States and by prescription in Brazil.

Brick-and-mortar stores interested in stocking oils and gummies of THCV, CBDV, CBDA, CBGA, CBC, CBG, CBN, and terpenes, can request a wholesale account on Wellness Orders. The website is the wholesale ordering site for both Rare Cannabinoid Company and Hawaiian Choice CBD.

Rare Cannabinoid Company believes strongly in cannabis and hemp education and has a list and map of third-party cannabinoid expert advisors. Cannabis doctors, nurses, and clinics can email [email protected] to inquire about being listed as an expert advisor. Customers seeking advice for specific ailments and conditions can contact these advisors for in-person and telehealth appointments. Find a cannabinoid advisor here. Each Rare Cannabinoid Company product page also has a "scientific studies" section with links to preclinical and medical research conducted on specific cannabinoids. Learn more and buy cannabinoids here.

Media Contact

Jennifer Carlile, Rare Cannabinoid Company, (808) 762-1313, [email protected]

Twitter, LinkedIn, Facebook

SOURCE Rare Cannabinoid Company

Modal title

This 1500mg cannabinoid tincture contains equal parts of CBGA, CBDA, and full spectrum Hawaiian CBD to support a healthy immune system.
This 1500mg cannabinoid tincture contains equal parts of CBGA, CBDA, and full spectrum Hawaiian CBD to support a healthy immune system.
This 1500mg cannabinoid tincture contains equal parts of CBGA, CBDA, and full spectrum Hawaiian CBD to support a healthy immune system.

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.